Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

Circadian aging and neurodegeneration: the emerging role of the melatonin-cortisol axis in brain homeostasis, disease progression, and precision chronomedicine

A summary of earlier studies · Frontiers in neuroendocrinology · Oct 26, 2026

What this means

Circadian aging may promote neurodegenerative illnesses by dysregulating the melatonin-cortisol axis. Low nighttime melatonin synthesis, blunted cortisol circadian cycles, abnormal clock-gene oscillation patterns, and sleep-wake architecture undermine central and peripheral circadian equilibrium with age.

A plain-English summary is on its way. Until then, this is the start of the authors' own summary.

Tested inSummary of earlier studies
Who it was tested in
Earlier studies
Kind of research
A summary of earlier studies

The science

Original title
Circadian aging and neurodegeneration: the emerging role of the melatonin-cortisol axis in brain homeostasis, disease progression, and precision chronomedicine.
Authors
Chakraborty W, Anand A, Kumar S et al.
Journal
Frontiers in neuroendocrinology
Published
Oct 26, 2026
Study type
Review

Abstract

Circadian aging may promote neurodegenerative illnesses by dysregulating the melatonin-cortisol axis. Low nighttime melatonin synthesis, blunted cortisol circadian cycles, abnormal clock-gene oscillation patterns, and sleep-wake architecture undermine central and peripheral circadian equilibrium with age. Neuroendocrine alterations produce oxidative stress, mitochondrial failure, pervasive neuroinflammation (CNS immune function loss), and proteostasis. Increasing Alzheimer's, Parkinson's, ALS, Huntington's, frontotemporal dementia, Lewy body disease, PTSD, and vascular cognitive impairment due to impaired glymphatic axonal clearance/blood-brain barrier dysregulation/synaptic degeneration/pathoproteopathic protein We examine how clock genes, melatonin signaling, hypothalamic-pituitary-adrenal axis administration, microglia reactivity, and immune-mediated metabolic dysregulation affect dementia. New endocrine, transcriptomic, multi-omics, and wearable-derived digital biomarkers, chronopharmacology (including melatonin receptor agonists), bright-light therapy, time-restricted eating with exercise chronotherapy guidance/synchronization, sleep optimization, and gut microbiota modulation This study addressed inter-individual circadian variability, genetic susceptibility to therapy timing, biomarker standardization, and clinical trial design. The melatonin-cortisol axis may identify and treat age-related neurodegenerative diseases with tailored treatment.

Read it on PubMed ↗

Chakraborty W, Anand A, Kumar S et al. Circadian aging and neurodegeneration: the emerging role of the melatonin-cortisol axis in brain homeostasis, disease progression, and precision chronomedicine. Frontiers in neuroendocrinology. 2026. doi:10.1016/j.yfrne.2026.101292. PMID: 42933736. https://pubmed.ncbi.nlm.nih.gov/42933736/

Related research

AnimalsStudy · microPublication biology · Oct 29, 2026

Short daily fasting extended lifespan in tiny worms

Worms fasted for part of each day lived longer than worms that did not fast. This work was in worms, so it does not show the same would happen in people.

Study · Cell · Oct 29, 2026

Calorie restriction uncouples mutation rate from lifespan.

In this issue of Cell, Grońska-Pęski et al. examine how calorie restriction (CR) affects DNA mutation rates.

Summary of earlier studiesReview · Current issues in molecular biology · Oct 27, 2026

Three common treatments and their possible links to aging and heart health

This review summarizes earlier studies on metformin, SGLT2 inhibitors, and fasting, and suggests a plan for using them together. It notes that key trials for fasting and for metformin in people without diabetes are missing.

Study · American journal of physiology. Cell physiology · Oct 26, 2026

Midlife time-restricted feeding preserves skeletal muscle insulin responsiveness and function during aging.

Primary sarcopenia, the progressive loss of skeletal muscle mass and function during aging, is partly driven by anabolic resistance, a reduced ability of aged muscle to activate protein synthesis in response to…

AnimalsLab or animal study · Biogerontology · Oct 23, 2026

LSD extended lifespan in tiny worms in a lab study

Researchers gave LSD to microscopic worms and found they lived longer, by up to 17.6 percent. This is a worm study, so it does not show LSD would extend human life.

Study · Cell · Oct 23, 2026

Taurine lowers inflammaging by regulating the NLRP3 inflammasome in macrophages.

Whether a decline in taurine drives aging is debated, and despite high millimolar intracellular concentrations, its function as a potential guardian of cytosolic homeostasis is unclear.

See all research on Calorie restriction and fasting →

Report a problem